Quality in screening colonoscopy: position statement of the European Society of Gastrointestinal Endoscopy (ESGE)

Many countries in Europe are now introducing screening for colorectal cancer 1. This considerable investment adds to national economic burdens and must be audited to demonstrate that it is cost-effective, well-targeted and of high quality. Spending more money, having more doctors, admitting more patients or having a nearby "center of excellence" does not necessarily result in improved outcomes.